Medicilon Assists Longsee Biomedical's LF01 capsules approved for clinical use
Medicilon
  • Reads 1
  • Votes 0
  • Parts 1
  • Time <5 mins
  • Reads 1
  • Votes 0
  • Parts 1
  • Time <5 mins
Medicilon
Ongoing, First published Dec 08, 2023
lf01
On November 20, LF01, an innovative anti-tumor drug independently developed by Longsee Biomedical Co. Ltd. (Longsee Biomedical), received the NMPA drug clinical trial approval notice.
All Rights Reserved
lf01
Table of contents

1 part

Sign up to add Medicilon Assists Longsee Biomedical's LF01 capsules approved for clinical use to your library and receive updates
or
Content Guidelines
You may also like
The Hidden Shadow by OutOfMyLimit17
42 parts Complete
A million dollar bounty, underground assassins, torture-it's all in a days work for assassin Jessie Wright. * * * * * * Molded into an assassin by the one who killed her parents, Jessie defies orders and goes rogue. Now with a bounty on her head, her only chance of survival may be with a man who's reputation is worse than her own. Violence, Assault, Swearing.
You may also like
Slide 1 of 1
The Hidden Shadow cover

The Hidden Shadow

42 parts Complete

A million dollar bounty, underground assassins, torture-it's all in a days work for assassin Jessie Wright. * * * * * * Molded into an assassin by the one who killed her parents, Jessie defies orders and goes rogue. Now with a bounty on her head, her only chance of survival may be with a man who's reputation is worse than her own. Violence, Assault, Swearing.

More details